Drotregocin alfa (activated) inhibits degradation of cytokine-mRNA in an endothelial model of inflammation

Similar Items

• Gene array transcript profiling of human endothelial cells identifies pathways regulated by Drotrecogin alfa (activated)
  od: Brueckmann, M, i dr.
  Izdano: (2003)
• Recombinant human activated protein C upregulates cyclooxygenase-2 and release of prostaglandins from cultured human endothelial cells via the endothelial protein C receptor
  od: Brueckmann, M, i dr.
  Izdano: (2004)
• TIMP-1, TIMP-2 and MMP-9 as prognostic markers for clinical outcome in sepsis
  od: Hoffmann, U, i dr.
  Izdano: (2003)
• Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
  od: Hoffmann, U, i dr.
  Izdano: (2004)
• Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts
  od: Omiya, Shigemiki, i dr.
  Izdano: (2020)